Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego · 2012
[Results of the MMPI-2 test among patients suffer from depressive disorders and organic depressive disorders].
Сравнительное исследованиеАннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Talarowska Monika, Zboralski Krzysztof, Gałecki Piotr
Аннотация
UNLABELLED: The Minnesota Multiphasic Personality Inventory (MMPI) is a psychological tool used in the diagnosis of various disorders and a helpful tool in determining the direction of the planned psychotherapeutic interactions. Is considered as a gold standard for diagnosis. The aim of the study was to compare the MMPI-2 test in patients with depressive disorders and organic depressive disorders.
MATERIAL AND METHODS: The study involved 79 people (41 women, 38 men), hospitalized in the Department of Adult Psychiatry Medical University of Łódź. The subjects were divided into two groups: patients with depressive disorders (DD, n = 53) and patients with organic depressive disorders (ODD, n = 26). The study used MMPI-2 test.
RESULTS: There were no statistically significant differences between the two groups in MMPI-2 test. Patients with DD have obtained higher scores on scales forming 'neurotic triad' (hypochondria, depression, hysteria), on a scale of psychopathy, psychasthenia and each of the five subscales of depression scale.
CONCLUSIONS: Patients with depressive disorders achieved higher results than patients with depressive disorders in hypochondria, depression, hysteria, psychopathy, psychasthenia, social introversion scale and each of the five subscales of depression scale. Patients with organic depressive disorders in the test MMPI-2 tend to aggravation (unconscious exaggeration of symptoms), and elevated results on a scale of paranoia, schizophrenia, mania and masculinity-femininity.
MATERIAL AND METHODS: The study involved 79 people (41 women, 38 men), hospitalized in the Department of Adult Psychiatry Medical University of Łódź. The subjects were divided into two groups: patients with depressive disorders (DD, n = 53) and patients with organic depressive disorders (ODD, n = 26). The study used MMPI-2 test.
RESULTS: There were no statistically significant differences between the two groups in MMPI-2 test. Patients with DD have obtained higher scores on scales forming 'neurotic triad' (hypochondria, depression, hysteria), on a scale of psychopathy, psychasthenia and each of the five subscales of depression scale.
CONCLUSIONS: Patients with depressive disorders achieved higher results than patients with depressive disorders in hypochondria, depression, hysteria, psychopathy, psychasthenia, social introversion scale and each of the five subscales of depression scale. Patients with organic depressive disorders in the test MMPI-2 tend to aggravation (unconscious exaggeration of symptoms), and elevated results on a scale of paranoia, schizophrenia, mania and masculinity-femininity.